AxioMx Lands $500,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    688 E Main Street Branford, CT 06405
  • Company Description
    AxioMx has developed synthetic recombinant antibody libraries with greater than ten billion unique clones. Diversity in our libraries is restricted to the most variable positions in the complementarity determining regions (CDRs) of natural antibody sequences. Our antibody frameworks have been optimized for protein expression, and our libraries efficiently generate binders to peptides as well as protein antigens.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Connecticut Innovations

Trending on Xconomy